Eshbach Megan L, Kaur Amandeep, Rbaibi Youssef, Tejero Jesús, Weisz Ora A
Renal-Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; and.
Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Am J Physiol Cell Physiol. 2017 Jun 1;312(6):C733-C740. doi: 10.1152/ajpcell.00021.2017. Epub 2017 Mar 29.
Proximal tubule (PT) dysfunction, including tubular proteinuria, is a significant complication in young sickle cell disease (SCD) that can eventually lead to chronic kidney disease. Hemoglobin (Hb) dimers released from red blood cells upon hemolysis are filtered into the kidney and internalized by megalin/cubilin receptors into PT cells. The PT is especially sensitive to heme toxicity, and tubular dysfunction in SCD is thought to result from prolonged exposure to filtered Hb. Here we show that concentrations of Hb predicted to enter the tubule lumen during hemolytic crisis competitively inhibit the uptake of another megalin/cubilin ligand (albumin) by PT cells. These effects were independent of heme reduction state. The Glu7Val mutant of Hb that causes SCD was equally effective at inhibiting albumin uptake compared with wild-type Hb. Addition of the Hb scavenger haptoglobin (Hpt) restored albumin uptake in the presence of Hb, suggesting that Hpt binding to the Hb αβ dimer-dimer interface interferes with Hb binding to megalin/cubilin. BLAST searches and structural modeling analyses revealed regions of similarity between Hb and albumin that map to this region and may represent sites of Hb interaction with megalin/cubilin. Our studies suggest that impaired endocytosis of megalin/cubilin ligands, rather than heme toxicity, may be the cause of tubular proteinuria in SCD patients. Additionally, loss of these filtered proteins into the urine may contribute to the extra-renal pathogenesis of SCD.
近端肾小管(PT)功能障碍,包括肾小管性蛋白尿,是年轻镰状细胞病(SCD)的一种重要并发症,最终可能导致慢性肾病。溶血时红细胞释放的血红蛋白(Hb)二聚体被滤入肾脏,并通过巨膜蛋白/立方蛋白受体内化进入PT细胞。PT对血红素毒性特别敏感,SCD中的肾小管功能障碍被认为是由于长期暴露于滤过的Hb所致。在这里,我们表明,预测在溶血危机期间进入肾小管腔的Hb浓度竞争性抑制PT细胞对另一种巨膜蛋白/立方蛋白配体(白蛋白)的摄取。这些效应与血红素还原状态无关。与野生型Hb相比,导致SCD的Hb的Glu7Val突变体在抑制白蛋白摄取方面同样有效。在存在Hb的情况下添加Hb清除剂触珠蛋白(Hpt)可恢复白蛋白摄取,这表明Hpt与Hbαβ二聚体-二聚体界面的结合会干扰Hb与巨膜蛋白/立方蛋白的结合。BLAST搜索和结构建模分析揭示了Hb和白蛋白之间的相似区域,这些区域映射到该区域,可能代表Hb与巨膜蛋白/立方蛋白相互作用的位点。我们的研究表明,巨膜蛋白/立方蛋白配体内吞作用受损而非血红素毒性可能是SCD患者肾小管性蛋白尿的原因。此外,这些滤过蛋白流失到尿液中可能导致SCD的肾外发病机制。